Adaptive Biotechnologies
ADPT
#3540
Rank
C$5.70 B
Marketcap
C$35.77
Share price
-1.72%
Change (1 day)
63.43%
Change (1 year)

Market capitalization of Adaptive Biotechnologies (ADPT)

Market cap: C$5.70 Billion

As of October 2026 Adaptive Biotechnologies has a market cap of C$5.70 Billion. This makes Adaptive Biotechnologies the world's 3540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Adaptive Biotechnologies from 2019 to 2026

End of year Market Cap

Year Marketcap Change
2026C$5.70 B66.9%
2025C$3.42 B169.03%
2024C$1.27 B35.11%
2023C$0.94 B-36.54%
2022C$1.48 B-70.62%
2021C$5.04 B-51.06%
2020C$10.31 B110.71%
2019C$4.89 B

End of Day market cap according to different sources

On Oct 14th, 2026 the market cap of Adaptive Biotechnologies was reported to be:

C$5.80 Billion
by Nasdaq info icon info icon
C$5.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HCA Healthcare
HCA
C$150.22 B 2,531.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Premier
PINC
C$3.31 B-41.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Community Health Systems
CYH
C$0.60 B-89.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Select Medical Holdings
SEM
C$2.90 B-49.08%๐Ÿ‡บ๐Ÿ‡ธ USA